Skip to content

Kawasaki study

Etiology, course and long-term effects of Kawasaki disease - Kawasaki disease study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON50455
Enrollment
850
Registered
2012-06-06
Start date
2013-06-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kawasaki disease

Interventions

None.

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
No minimum to 99 Years

Inclusion criteria

Inclusion criteria: - Diagnosis of Kawasaki disease according to a standard set of clinical criteria - Kawasaki disease between the age of 0-18 years - Inclusion of 300 new cases per 5 years (there are about 100 cases per year in  The Netherlands), which would be 600 cases over the next 10 years.

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

MeasureTime frame
1. Causative agents: one or more viruses / bacteria involved in triggering Kawasaki disease 2. Genetics: genetic variations in the human genome is associated with disease susceptibility, course of the disease (coronary artery aneurysms), and the clinical reaction to standard treatment with IVIG 3. Biomarkers: generate novel diagnostic tests 4. Long-term effects: assessment of a cardiovascular risk profile

Secondary

MeasureTime frame
None.

Countries

Netherlands

Contacts

Public ContactT.W. Kuijpers

Amsterdam UMC

kawasaki-studies@amsterdamumc.nl020 5669111

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Feb 3, 2026